Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

DOW B dermatitis0

VIEWS: 3 PAGES: 2

DOW B dermatitis0

More Info
									Revised: 7/25/2010

                               MARCIA STARNS, MPAS, PA-C
                                                    CURRICULUM VITAE


OFFICE LOCATIONS:                     THE DERMATOLOGY CLINIC                                   Licensure in the following states:
                                      3633 Central Avenue, Suite N                                      Arkansas
                                      Hot Springs, Arkansas, 71913                                      Ohio
                                                                                                        North Carolina
                                      Telephone: (501) 623-6100                                         Pennsylvania (Inactive)
                                      Fax:       (501) 623-6187
                                      E-mail:    mstarns@burkepharmaceutical.com

EDUCATION:                            Master of Physician Assistant Studies
                                      Chatham College, Pittsburgh, Pennsylvania, 2001
                                                  Clinical Rotations: Primary Care, Pediatrics, Orthopedics, Neurology, Obstetrics &
                                                   Gynecology, General Surgery, Rehabilitation Medicine, Psychiatry, and Emergency
                                                   Medicine

                                      Master of Science in Zoology
                                      Miami University, Oxford, Ohio, 1975
                                                   Graduate Teaching Assistant in Anatomy and Physiology

                                      Bachelor of Arts in Biology
                                      Ottawa University, Ottawa, Kansas, 1973
                                                   Comprehensive Exams Passed With Distinction

                                      Graduate of EMT-Paramedic Program
                                      Aultman Hospital, Canton, Ohio, 1995


CERTIFICATIONS & REGISTRATIONS:                                    DEA Registration - Active
                                                                   ACLS, BTLS, CPR – Current


MEMBERSHIPS:                          (AAPA) American Academy of Physician Assistants
                                      (NCCPA) National Commission on Certification of Physician Assistants
                                      (SDPA) Society of Dermatology Physician Assistants



EMPLOYMENT HISTORY:

BURKE PHARMACEUTICAL RESEARCH
Hot Springs, Arkansas – Clinical Trial Sub Investigator, December 2004 – present
Patient exams, case management of clinical trial subjects.

THE DERMATOLOGY CLINIC
Hot Springs, Arkansas - Dermatology Physician Assistant, December 2004 – present
General Dermatology patients

ADVANCED DERMATOLOGY CENTER
Gastonia & Huntersville, North Carolina, May 2004 – November 2004
General dermatology, Mohs surgical assisting.

CAROLINA SKIN CARE
Pinehurst, North Carolina, July 2003 – October 2003 (Locum Tenens)
General dermatology

OHIO STATE UNIVERSITY MEDICAL CENTER & JAMES CANCER HOSPITAL
Columbus, Ohio – October 2001-October 2002
Cardiothoracic Surgical Assisting and Oncology




                                                                     1
Revised: 7/25/2010


CLINICAL TRIALS: Experienced in Phase I-IV Studies
Phase III   Effect of nasal spray on the hypothalamic pituitary adrenocortical (HPA) axis in pediatric subjects 2 to < 12 years of age with
            Perennial allergic rhinitis (PAR)
Phase III   Topical Treatment of Atopic Dermatitis
Phase III   IM Treatment for Plaque Psoriasis
Phase I     New oral therapy in Refractory Cutaneous T-Cell Lymphoma
Phase II    Pediatric Rhinitis Nasal spray efficacy
Phase III   Efficacy of two manufacturer’s Clotrimazole cream(s) for the Indication of Tinea Versicolor
Phase III   Controlled Clinical Trial to evaluate bioequivalence of benzoyl peroxide/clindamycin preparations in treatment of Acne Vulgaris
Phase III   Vehicle controlled study of ethanol-free steroid foam in treatment of Atopic Dermatitis
Phase II     Study of new molecule cream in the treatment of Atopic Dermatitis in Pediatric and Adolescent patients.
Phase III   Vehicle controlled study of immuno modifying topical cream in actinic keratosis treatment
Phase III   Vehicle controlled study of steroid cream in pediatric Atopic Dermatitis
Phase I     Vehicle controlled study of adult Atopic Dermatitis treated with novel molecule.
Phase II    Open label study safety and efficacy of Ketaconozole in the treatment of adult seborrheic dermatitis.
Phase III   Long term safety study for an oral antibiotic for the treatment of moderate to severe acne
BE study    Two way crossover bioavailability study of sponsor drug and Mission Pharmacal drug in healthy male volunteers
Phase III   Topical therapy for mild to severe plaque psoriasis
Phase IIa    Topical novel molecule for treatment of male androgenetic alopecia
Phase III   Study of efficacy and safety of new dosing famciclovir compared to acyclovir for recurrent Genital Herpes
Phase II    Novel topical cream for treatment of Adolescent Psoriasis
Phase II    Randomized, Double-blind, parallel group vehicle-controlled, multiple dose, proof of concept study of topical novel molecule for
            Solar Lentigines
Phase II    Efficacy and safety of combination retinoid/benzoyl peroxide compared to each monad and vehicle in mild to moderate acne
Phase III   Study of oral antifungal agent in novel dosing regimen for fingernail onychomycosis
Phase III   Double blind, vehicle-controlled, parallel group study comparing 5% Imiquimod (Aldara/TM) to 5% Imiquimod
Phase III   Impetigo Study, topical treatment
Phase IV    Cognitive impairment study related to sedating antihistamines
Phase III   Topical acne treatment
Phase III   One year allergic rhinitis study for nasal spray treatment
Phase II     Osteoarthritis of the Knee oral anti-inflammatory in double-blind,placebo and positive controlled study
Phase IV    Topical preparation for xerosis and atopic dermatitis
Phase II    Topical Acne treatment; multiple studies


CLINICAL TRIALS LISTED ABOVE WERE CONDUCTED BY THE FOLLOWING COMPANIES:
Altana, Astellas, Dow, GlaxoSmithKline, Connetics, Serono, Nucryst, Symbio, Ferndale, Anacor, Barrier, Biocryst, Medicis, Cypress
Pharmaceuticals, Paddock Laboratories, Pfizer, Genomics, Novartis, Hill, Teva, Alcon, Glenmark, Schering Plough, Galderma, CuTech,
Clinimetrics, Pracs, Peplin, Hoffman Roche, Clynsis, Parexel, Novum, Alcon, TKL.



INDICATIONS:
Atopic Dermatitis/ Acne/ Actinic Keratosis/ Allergic Rhinitis (PAR)/Asthma/ Bioequivalence/ Psoriasis/ Tinea Versicolor/
Cutaneous T-Cell Lymphoma/ Tinea Pedis/ Male Androgenetic Alopecia/ Genital Herpes/ Adolescent Psoriasis/ Solar Lentigines/
Eczema/ Fingernail Onychomycosis/ Toenail Onychomycosis/ Impetigo/ Osteoarthritis of Knee/ Antihistaminic Sedation/Diabetes.

PUBLICATION:
Principal Investigator, Master’s Project Research Group: “Assessment of Patient Knowledge Regarding the Benefit of Physical Activity for
Depressed Mood” presented American Academy of Physician Assistants Poster Presentation, AAPA National Conference, May 2001

COMMUNITY SERVICE:
HUDSON EMERGENCY MEDICAL SERVICE
Hudson, Ohio 1993-1999
NREMT-PARAMEDIC




                                                                       2

								
To top